The Prognostic Value of Biomarkers and the Effect of Tolperisone in Acute Low Back Pain and Sciatic Pain "BETA"

NCT05544656 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Low Back Pain

Interventions

DRUG: Tolperisone Hydrochloride
DRUG: Placebo

Sponsor

Semmelweis University

Collaborators

[object Object]
[object Object]